Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001367644-25-000136
Filing Date
2025-05-28
Accepted
2025-05-28 16:08:23
Documents
1
Period of Report
2025-05-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1748462897.html 4  
1 FORM 4 wk-form4_1748462897.xml 4 3761
  Complete submission text file 0001367644-25-000136.txt   5200
Mailing Address C/O UROVANT SCIENCES, INC. 5281 CALIFORNIA AVENUE, SUITE 100 IRVINE CA 92617
Business Address
Katkin Keith (Reporting) CIK: 0001314596 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 25995490

Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)